Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 years.
Tréluyer L, Zana-Taieb E, Jarreau PH, Benhammou V, Kuhn P, Letouzey M, Marchand-Martin L, Onland W, Pierrat V, Saade L, Ancel PY, Torchin H.
Tréluyer L, et al. Among authors: torchin h.
Arch Dis Child Fetal Neonatal Ed. 2024 Jun 19;109(4):443-449. doi: 10.1136/archdischild-2023-326170.
Arch Dis Child Fetal Neonatal Ed. 2024.
PMID: 38228381